Indian drugmaker Solara Active Pharma is nearing to raise $30 million in an investment round.

The investments will come from TPG Growth, part of U.S. private equity and venture capital firm TPG Capital.

Solara Active Pharma said that the funds will support its expansion in regulated markets.

The deal will close in early 2019, subject to shareholder and regulatory approval. Following the closure of the round, TPG Growth will join Solara’s board of directors.